Supply Chain Finance Fuels Boston Scientific’s Aggressive Acquisition Strategy and Increases Market Value
By PrimeRevenue • Published December 16, 2019 • 2 minute read
Boston Scientific, a $9 billion global leader in medical technological innovation, is one of the world’s largest manufacturers of medical devices. As part of its long-term growth strategy, Boston Scientific invests heavily in strategic acquisition (there have been more than 30 since 2004) and increasing market value through improved financials.
Supply Chain Finance Fuels Boston Scientific’s Aggressive Acquisition Strategy and Increases Market Value
